Market Signal Briefing

HUNTER launches Hi⁵ Framework: AI-driven brand discovery solution for zero-click search optimizationSolves critical "agentic era" challenge where AI systems directly recommend brands without clickthroughFramework includes 5 core components: Hunt, Highlight, Hook, Halo, and HoldPowered by partnerships with 5 leading tech providers: Scrunch, Muck Rack, The Marketing Cloud, LLMtel, and Mira Studio from Meltwater NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- HUNTER, a leading integrated marketing and PR firm known for earning consumer attention and elevating corporate reputation, today announced HUNTER: Hi⁵, a new agency capability that builds brand visibility through a five-step generative engine optimization (GEO) framework.

Why This Matters Now
As AI agents increasingly gatekeep consumer discovery in zero-click environments, brands face a fundamental shift: success now depends on being cited, recommended, and trusted by AI systems that deliver information directly to consumers.

HUNTER: Hi⁵ addresses this shift by building the credibility that compels AI systems to cite, recommend, and trust certain brands over competitors. HUNTER has advised organizations across beauty, fashion, technology, luxury, and food and beverage on successful AI integration, with a particular focus on optimizing press releases and brand-owned sites to maximize agent visibility. HUNTER: Hi⁵ packages these services into an efficient, actionable, and measurable new solution.

“Agents are the new personal shoppers for information. We make them your advocates, so your brand goes from seen to sourced,” said Michael Lamp, Chief Digital & Social Officer, HUNTER. “Our Hi⁵ framework builds credibility into every touchpoint so agents trust, choose, and recommend you. That’s brand discovery for the agentic era.”

How Hi⁵ Works:

Hunt: for brand visibility and white space.Highlight: the brand’s story for maximum visibility.Hook: LLMs with the right media outreach.Halo: reach of coverage and conversationHold: your brand position as a preferred source.
What Hi⁵ Delivers:

30 days: Trust graph audit and AI visibility report, schema/FAQ plan, press TL; DR templates60–90 days: Expert content packages, structured site update recommendations, full-scale press and website toolkitsOngoing: Citation share growth, lift in answer visibility rate, and a defensible credibility moat
“AI systems increasingly control how consumers discover brands, and this evolution particularly emphasizes the exponential power of earned media and the need for GEO-aware approach for driving coverage,” said Grace Leong, CEO of HUNTER. “By offering the HUNTER: Hi⁵, we’re providing our clients with an impactful PR-led solution that will maximize agent visibility while also future-proofing brands for AI-driven consumer behavior shifts.”

HUNTER: Hi⁵ is powered by strategic partnerships with leading technology and data providers to deliver real-time brand intelligence; these partners include:

Brand Monitoring & Recognition: LLMtel provides directional overviews, alerting brands when their messages aren't being recognized by AI systems, enabling rapid responses to visibility gaps and website optimization recommendations to help establish authority with AI systems.Query Intelligence & Impact Tracking: Scrunch tracks the volume of category-related queries to measure answer rate, citation rate and domain authority over time; scans brand websites to unearth how AI crawlers discover and evaluate content.Editorial Insights & Trend Analysis: Mira Studio, Meltwater's AI-powered teammate, delivers deeper insights about editorial coverage and trending topics to better unite earned with owned, while Generative Pulse Muck Rack’s tool that helps brands understand how they appear in generative AI search, surfaces top brands, domains, outlets and editors to ensure media outreach is targeted to the journalists most trusted by LLMs, while also measuring AI sentiment and visibility over time.Secure AI Agent Development: The Marketing Cloud enables HUNTER to use walled AI environments and build secure agents for client work, ensuring proprietary strategies remain confidential while maximizing Hi⁵ implementation effectiveness. Frequently recognized as a “Best Place to Work,” Large Agency of the Year and Consumer Agency of the Year, HUNTER drives growth and earns valuable attention and reputation for consumer and corporate clients across food & beverage, travel, home & lifestyle, technology, financial services, retail, and health & beauty sectors.

Say Hi⁵ to the future. For more information on how your brand can compete in AI-powered search, contact [email protected].

About HUNTER:
Founded in 1989, HUNTER is an award-winning marketing communications firm with offices in New York, Los Angeles, Chicago, Toronto and London and a footprint across North America. Beginning with research-driven consumer insights, HUNTER executes strategic, integrated programs that build brand equity, increase engagement and drive measurable business results for B2B and consumer products and services. The 325-person firm employs a powerful blend of marketing solutions including strategic planning, social and digital media, talent and influencer engagement, media relations, experiential and multicultural marketing, and content creation and distribution for all platforms and channels to earn consumer attention and elevate corporate reputation for some of the world’s best known and most beloved brands. The agency is a member of Stagwell Inc. (NASDAQ:STGW).

About The Marketing Cloud:
The Marketing Cloud (formerly Stagwell Marketing Cloud) is a data-driven suite of AI-powered SaaS and service solutions built for the modern marketer. Powered by proprietary data and advanced tools spanning research, communications, creative, and media, it enables organizations to achieve measurable business outcomes by making smarter decisions, faster. The Marketing Cloud was born out of Stagwell’s (NASDAQ: STGW) award-winning network, known for delivering creative performance for ambitious brands.

Contact: 
Shanice Graves
[email protected]

Frequently Asked Questions

Q: What is the HUNTER: Hi⁵?

A: Hi⁵ is HUNTER’s five-step GEO framework that earns visibility inside AI answers and citations as the source. We Hunt, Highlight, Hook, Halo, and Hold, building your credibility so LLMs trust, choose, and share your brand.

Q: How does Hi⁵ differ from traditional SEO?

A: SEO optimizes for rankings and clicks. Hi⁵ optimizes for Answer Visibility and Citation Share inside AI outputs. We structure press, web and social for extraction, then measure and defend your position as agents’ preferred source.

Q: Which industries benefit most from GEO/AEO?

A: Any category where AI agents influence discovery or purchase decisions: CPG, beauty, retail, food & beverage, health, tech, travel, and finance. If customers ask AI for advice, GEO drives outcomes.

Q: What results can brands expect and when?

A: Early signals appear within days, based on the recency bias present in earned media; more appearances in AI answers, rising citation frequency and reduced competitive displacement will take shape over 60-90 days. We baseline Answer Visibility and Citation Share, then report gains by query cluster and platform.

Q: How does HUNTER measure AI visibility and citation?

A: We track several key metrics to show how often you appear in AI answers. This includes Answer Visibility (how often your brand shows up), Citation Share (how often you're credited as a source), Recommendation Rate (how frequently AI suggests you), Source Coverage (how many platforms feature you), Schema Health (how well-structured your website data is for AI to read), Freshness Velocity (how quickly new content gets picked up), and Competitive Displacement (how you compare to competitors). Think of it like SEO rankings, but for AI tools instead of search engines.

Q: What does implementation require from us?

A: Access to brand experts and existing content, analytics/CMs logins and approval for structured updates (schema, FAQs, TL;DRs). We run a trust-graph audit (visibility reporting), then ship press/web/social upgrades in toolkits or bundles.

Q: Why is HUNTER the right partner for GEO in 2026?

A: Earned first DNA plus technical rigor. We blend media relationships with structured content engineering, so your expertise is impossible to ignore and easy to cite.

Key Agency Data Points:

HUNTER has been in business for 36 years.Five consecutive years of double-digit growthFive global office locationsCurrent client roster includes Fortune 500 brandsInaugural client relationship spanning 36 years

Enhances WTW’s presence in the fast-growing U.S. middle market and high-growth specialties, including technology, fintech, and life sciencesBrings innovative technology and agentic AI capabilities that complement WTW’s recent technology, data and analytics investments and accelerate WTW’s technology strategyPurchase price of $1.05 billion at closing and up to $250 million of contingent consideration LONDON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW) (the “Company”), a leading global advisory, broking and solutions company, announced it has signed a definitive agreement to acquire Newfront, a San Francisco-based, top 40 U.S. broker combining deep specialty expertise and cutting-edge technology. The agreement provides for upfront and contingent consideration payments totaling $1.3 billion. The upfront portion of $1.05 billion is comprised of approximately $900 million in cash and $150 million in equity to be paid to Newfront employee-shareholders; the contingent consideration of up to $250 million is payable primarily in equity, subject to Newfront’s achievement of specified performance targets. Additionally, up to an incremental $150 million payable primarily in equity would become payable if Newfront achieves above-target revenue growth. The transaction is expected to close during the first quarter of 2026, subject to receipt of certain regulatory approvals and other customary closing conditions.

The acquisition of Newfront expands WTW’s reach in the U.S. middle market and presence within high-growth specialties including technology, fintech and life sciences. Newfront’s two business segments, Business Insurance and Total Rewards, will be combined with WTW’s Risk & Broking (R&B) and Health, Wealth & Career (HWC) segments, respectively. Newfront has grown organic revenue at a 20% CAGR between 2018-2024, driven by its growing producer base, proprietary client-facing technologies and use of cutting-edge agentic AI. The integration of Newfront’s technology platforms and more than 120 producers will position WTW to accelerate deployment of capabilities across both R&B and HWC.

“We’re delighted to welcome Newfront to the WTW team as we take an important step forward in executing on our strategy through a transaction that will drive value creation for our clients, colleagues and shareholders,” said Carl Hess, WTW’s Chief Executive Officer. “The Newfront team has built a broking business, powered by exceptional technology that offers a smart, fast and efficient client experience and complements our own technology investments. This combination strengthens our presence in the U.S. middle market, accelerates our technology and specialty strategies, and enables the delivery of an integrated, end-to-end technology platform that will drive growth, enhance operational efficiency and better serve our clients.”

“Newfront is excited to join WTW and combine our technology-native approach to insurance broking with WTW’s global presence and established trading, analytics and broking platforms,” said Spike Lipkin, Co-Founder and Chief Executive Officer of Newfront. “WTW’s culture and strategic focus on specialization and technology are a strong fit for Newfront, and we will work together to bring an innovative and efficient broking experience to our combined global client base. We will continue to serve our clients with the speed and intelligence they expect and will offer new capabilities enabled by WTW’s comprehensive portfolio of global solutions and products.”

Unparalleled Combined Technological Capabilities

Newfront’s technology platform complements WTW’s technology foundation and builds on its recent strategic investments in this area. Newfront has developed a modern client-facing interface, Navigator, and agentic AI-driven placement automation capabilities that allow Newfront to sell to and serve clients more productively than other brokers. Together with WTW’s digital trading platform (Neuron), risk models, data analytics and digital submission capabilities, these technologies will create an end-to-end digital ecosystem enabling brokers to serve clients of all sizes with greater speed, efficiency and intelligence. The combination of these systems will accelerate progress on WTW’s technology roadmap and strengthen capabilities across several strategic areas:

Differentiating the client and broker experience with intuitive, AI-enabled tools, enabling quicker decision-making and executionImproving sales productivity by empowering smaller teams to handle high volumes effectivelyEnhancing efficiency for middle-market clients by delivering scalable high-quality supportExpediting cross-sell opportunities by bringing the full breadth of WTW’s existing solutions into a seamless interfaceCombining WTW’s technology talent base with a core team of highly skilled engineers Financial Terms

Upfront and contingent consideration payments total $1.3 billion. The upfront portion of $1.05 billion is comprised of approximately $900 million in cash and approximately $150 million in equity to be paid to Newfront employee-shareholders; the contingent consideration of up to $250 million is payable primarily in equity, subject to Newfront’s achievement of specified three-year performance targets. Additionally, up to an incremental $150 million payable primarily in equity would become payable after the third anniversary of closing if Newfront achieves above-target revenue growth. WTW will also provide equity-based retention incentives totaling $100 million for Newfront employees through 2031.

WTW expects to realize run-rate cost synergies of approximately $35 million by the end of 2028, driven primarily by technology-driven efficiencies and overhead optimization across both Newfront and WTW. WTW expects to incur transaction expense of $25 million and cash integration costs of approximately $100 million, including technology integration, systems alignment and employee-related costs, as well as approximately $30 million of one-time non-cash expenses.

The transaction is expected to be approximately $0.10 dilutive to Adjusted EPS in 2026 and accretive to Adjusted EPS in 2027.

Conference Call

The Company will host a conference call to discuss the transaction. It will be held on Wednesday, December 10, 2025, beginning at 9:00 a.m. Eastern Time. A live, listen-only webcast of the conference call and supplemental materials will be available on WTW’s website. Analysts and institutional investors may participate in the conference call’s question-and-answer session by registering in advance here. An online replay will be available at investors.wtwco.com shortly after the call concludes.

Advisors

J.P. Morgan Securities LLC is acting as exclusive financial advisor and Weil, Gotshal & Manges LLP as legal advisor to WTW. Perella Weinberg is serving as exclusive financial advisor and Reed Smith LLP as legal advisor to Newfront.

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you. Learn more at www.wtwco.com.

About Newfront

Newfront is a modern brokerage transforming the risk management, business insurance, total rewards, and retirement services space through the combination of elite expertise and cutting-edge technology. Specializing in more than 20 industries and headquartered in San Francisco, Newfront has offices nationwide and is home to more than 650 employees serving organizations across the United States and globally. Learn more at www.newfront.com.

Contacts

Claudia De La Hoz
WTW Investor Relations
email [email protected]
phone +1 215 246 6221

Miles Russell
WTW External Communication
email [email protected]
phone +44 (0) 7903 262 118

WTW Forward-Looking Statements

This document contains ‘forward-looking statements’ within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by those laws. You can identify these statements and other forward-looking statements by words such as ‘may’, ‘will’, ‘would’, ‘commit’, ‘anticipate’, ‘believe’, ‘estimate’, ‘expect’, ‘intend’, ‘plan’, ‘continues’, ‘seek’, ‘target’, ‘goal’, ‘focus’, ‘probably’, or similar words, expressions or the negative of such terms or other comparable terminology. These forward-looking statements include, but are not limited to, our agreement to acquire Newfront (the “Proposed Transaction”), expectations relating to the Proposed Transaction or the potential benefits or consequences of the Proposed Transaction, information about possible or assumed future results of our operations including without limitation results of the acquired business and potential synergy opportunities, the anticipated timeline for the completion of the Proposed Transaction and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. All forward-looking disclosure is speculative by its nature.

There are important risks, uncertainties, events and factors that could cause our actual results or performance to differ materially from those in the forward-looking statements contained in this document, including the following: our ability to complete the Proposed Transaction, including obtaining the required customary regulatory approvals, in the anticipated timeline or at all; our ability to effectively integrate Newfront into our business and operations; our ability to achieve the expected results of the Proposed Transaction; our ability to execute on our strategy, optimize our portfolio, accelerate performance or enhance efficiency; our ability to deliver substantial value to our stakeholders; changes in general economic, business and political conditions, including changes in the financial markets; significant competition in the marketplace; and compliance with extensive government regulation. Factors also include those described under Part I, Item 1A in our Annual Report on Form 10-K, and our subsequent filings with the SEC. Copies are available online at http://www.sec.gov or www.wtwco.com. The foregoing list of factors is not exhaustive and new factors may emerge from time to time that could also affect actual performance and results.

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and therefore also the forward-looking statements based on these assumptions, could themselves prove to be inaccurate. Given the significant uncertainties inherent in the forward-looking statements included in this document, our inclusion of this information is not a representation or guarantee by us that our objectives and plans will be achieved.

Our forward-looking statements speak only as of the date made and we will not update these forward-looking statements unless the securities laws require us to do so. With regard to these risks, uncertainties and assumptions, the forward-looking events discussed in this document may not occur, and we caution you against unduly relying on these forward-looking statements.

WTW Non-GAAP Measures

In order to assist readers of our consolidated financial statements in understanding the core operating results that WTW’s management uses to evaluate the business and for financial planning, we present the following non-GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted Operating Income/Margin, (4) Adjusted EBITDA/Margin, (5) Adjusted Net Income, (6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before Taxes, (8) Adjusted Income Taxes/Tax Rate, (9) Free Cash Flow and (10) Free Cash Flow Margin.

We believe that those measures are relevant and provide pertinent information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating performance, and in the case of free cash flow, our liquidity results.

Within the measures referred to as ‘adjusted’, we adjust for significant items which will not be settled in cash, or which we believe to be items that are not core to our current or future operations. Some of these items may not be applicable for the current quarter, however they may be part of our full-year results. Additionally, we have historically adjusted for certain items which are not described below, but for which we may adjust in a future period when applicable. Items applicable to the quarter or full year results, or the comparable periods, include the following:

Restructuring costs and transaction and transformation – Management believes it is appropriate to adjust for restructuring costs and transaction and transformation when they relate to a specific significant program with a defined set of activities and costs that are not expected to continue beyond a defined period of time, or significant acquisition-related transaction expenses. We believe the adjustment is necessary to present how the Company is performing, both now and in the future when the incurrence of these costs will have concluded.Impairment – Adjustment to remove the non-cash goodwill impairment associated with our Benefits, Delivery and Administration (‘BDA’) reporting unit related to the sale of our TRANZACT business.Provisions for specified litigation matters – We will include provisions for litigation matters which we believe are not representative of our core business operations. Among other things, we determine this by reference to the amount of the loss (net of insurance and other recovery receivables) and by reference to whether the matter relates to an unusual and complex scenario that is not expected to be repeated as part of our ongoing, ordinary business. These amounts are presented net of insurance and other recovery receivables. See the footnotes to the reconciliation tables below for more specificity on the litigation matter excluded from adjusted results.Gains and losses on disposals of operations – Adjustment to remove the gains or losses resulting from disposed operations that have not been classified as discontinued operations.Net periodic pension and postretirement benefits – Adjustment to remove the recognition of net periodic pension and postretirement benefits (including pension settlements), other than service costs. We have included this adjustment as applicable in our prior-period disclosures in order to conform to the current-period presentation.Tax effect of significant adjustments – Relates to the incremental tax expense or benefit resulting from significant or unusual events including significant statutory tax rate changes enacted in material jurisdictions in which we operate, internal reorganizations of ownership of certain businesses that reduced the investment held by our U.S.-controlled subsidiaries and the recovery of certain refunds or payment of taxes related to businesses in which we no longer participate. We evaluate our revenue on an as reported (U.S. GAAP), constant currency and organic basis. We believe presenting constant currency and organic information provides valuable supplemental information regarding our comparable results, consistent with how we evaluate our performance internally.

We consider Constant Currency Change, Organic Change, Adjusted Operating Income/Margin, Adjusted EBITDA/Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Adjusted Income Before Taxes, Adjusted Income Taxes/Tax Rate and Free Cash Flow to be important financial measures, which are used to internally evaluate and assess our core operations and to benchmark our operating and liquidity results against our competitors. These non-GAAP measures are important in illustrating what our comparable operating and liquidity results would have been had we not incurred transaction-related and non-recurring items. Reconciliations of these measures are included in the accompanying tables with the following exception: The Company does not reconcile its forward-looking non-GAAP financial measures to the corresponding U.S. GAAP measures, due to variability and difficulty in making accurate forecasts and projections and/or certain information not being ascertainable or accessible; and because not all of the information, such as foreign currency impacts necessary for a quantitative reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP financial measure, is available to the Company without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non-GAAP financial measures that it believes will be achieved, however it cannot accurately predict all of the components of the adjusted calculations and the U.S. GAAP measures may be materially different than the non-GAAP measures.

Our non-GAAP measures and their accompanying definitions are presented as follows:

Constant Currency Change – Represents the year-over-year change in revenue excluding the impact of foreign currency fluctuations. To calculate this impact, the prior year local currency results are first translated using the current year monthly average exchange rates. The change is calculated by comparing the prior year revenue, translated at the current year monthly average exchange rates, to the current year as reported revenue, for the same period. We believe constant currency measures provide useful information to investors because they provide transparency to performance by excluding the effects that foreign currency exchange rate fluctuations have on period-over-period comparability given volatility in foreign currency exchange markets.

Organic Change – Excludes the impact of fluctuations in foreign currency exchange rates, as described above and the period-over-period impact of acquisitions and divestitures on current-year revenue. We believe that excluding transaction-related items from our U.S. GAAP financial measures provides useful supplemental information to our investors, and it is important in illustrating what our core operating results would have been had we not included these transaction-related items, since the nature, size and number of these transaction-related items can vary from period to period.

Adjusted Operating Income/Margin – Income/(Loss) from operations adjusted for impairment, amortization, restructuring costs, transaction and transformation and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted operating income margin is calculated by dividing adjusted operating income by revenue. We consider adjusted operating income/margin to be important financial measures, which are used internally to evaluate and assess our core operations and to benchmark our operating results against our competitors.

Adjusted EBITDA/Margin – Net Income/(Loss) adjusted for provision for income taxes, interest expense, impairment, depreciation and amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations, net periodic pension and postretirement benefits, and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted EBITDA Margin is calculated by dividing adjusted EBITDA by revenue. We consider adjusted EBITDA/margin to be important financial measures, which are used internally to evaluate and assess our core operations, to benchmark our operating results against our competitors and to evaluate and measure our performance-based compensation plans.

Adjusted Net Income – Net Income/(Loss) Attributable to WTW adjusted for impairment, amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations, net periodic pension and postretirement benefits, and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results and the related tax effect of those adjustments and the tax effects of internal reorganizations. This measure is used solely for the purpose of calculating adjusted diluted earnings per share.

Adjusted Diluted Earnings Per Share – Adjusted Net Income/(Loss) divided by the weighted-average number of ordinary shares, diluted. Adjusted diluted earnings per share is used to internally evaluate and assess our core operations and to benchmark our operating results against our competitors.

Adjusted Income Before Taxes – Income/(Loss) from operations before income taxes and interest in earnings of associates adjusted for impairment, amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations, net periodic pension and postretirement benefits, and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted income before taxes is used solely for the purpose of calculating the adjusted income tax rate.

Adjusted Income Taxes/Tax Rate – (Provision for)/benefit from income taxes adjusted for taxes on certain items of impairment, amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations, net periodic pension and postretirement benefits, the tax effects of significant adjustments and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results, divided by adjusted income before taxes. Adjusted income taxes is used solely for the purpose of calculating the adjusted income tax rate. Management believes that the adjusted income tax rate presents a rate that is more closely aligned to the rate that we would incur if not for the reduction of pre-tax income for the adjusted items and the tax effects of internal reorganizations, which are not core to our current and future operations.

Free Cash Flow – Cash flows from operating activities less cash used to purchase fixed assets and software. Free Cash Flow is a liquidity measure and is not meant to represent residual cash flow available for discretionary expenditures. Management believes that free cash flow presents the core operating performance and cash-generating capabilities of our business operations. As a result of our change in presentation, free cash flow for the prior period has been adjusted to conform to the current period, which includes the deduction of our capitalized software costs.

Free Cash Flow Margin – Free Cash Flow as a percentage of revenue, which represents how much of revenue would be realized on a cash basis. We consider this measure to be a meaningful metric for tracking cash conversion on a year-over-year basis due to the non-cash nature of our pension income, which is included in our GAAP and Non-GAAP earnings metrics presented herein.

These non-GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measures of other companies. Non-GAAP measures should be considered in addition to, and not as a substitute for, the information contained within our condensed consolidated financial statements.

The company, also backed by Bill Gates's Breakthrough Energy Ventures, has emerged as a leader in advanced geothermal energy.

, /PRNewswire/ -- On December 9, 2025, the board of directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on February 4, 2026, to shareholders of record on January 28, 2026.

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.  

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. 

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

SOURCE West Pharmaceutical Services, Inc.

December 10, 2025 6:00 AM EST | Source: Nexus Uranium Corp.
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2025) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: JA7) ("Nexus" or the "Company") is pleased to announce the appointment of Jon Winter to the Company's Advisory Board, effective December 1st, 2025.

Mr. Winter brings more than 40 years of experience in environmental permitting, regulatory affairs, and mine-site operations across North America and Central America. His appointment strengthens Nexus' advisory capabilities as the Company advances its uranium project portfolio through the permitting and development process.

"Jon's extensive experience in uranium permitting and environmental compliance, specifically with respect to the permitting of enCore Energy's Dewey-Burdock project, represents a significant addition to our team," said Jeremy Poirier, Chief Executive Officer. "His hands-on operational background at in-situ uranium facilities, combined with his track record of securing permits from federal and state agencies, will be invaluable as we advance our U.S. uranium projects toward development."

About Jon Winter

Mr. Winter has over 40 years of experience in the extractive industries and public service. He has worked in the mining environmental health and safety field on permits for development projects and operating facilities, site compliance management, ISO 14001 Environmental Management, mine site reclamation, and management of municipal public works.

Mr. Winter has been involved at the operational level at in-situ uranium and surface gold mining operations in Wyoming, South Dakota, Washington State, Colorado, and Honduras. He has been a key team member in the development of permits and approvals from multiple state and federal agencies, including the U.S. Nuclear Regulatory Commission (NRC), Environmental Protection Agency (EPA), Bureau of Land Management (BLM), U.S. Forest Service (USFS), U.S. Fish and Wildlife Service (USF&W), and the U.S. Army Corps of Engineers (USACE).

Mr. Winter holds degrees in Biology and Rangeland Ecology from Mesa State College and the University of Wyoming.

In connection with his appointment, the Company has granted 30,000 restricted share units ("RSUs") to Mr. Winter pursuant to the Company's omnibus equity incentive compensation plan. The RSUs vest equally in 25% tranches over 12 months beginning on the date of grant, and each RSU entitles the holder to one common share of the Company upon vesting. The RSUs and the underlying shares are subject to restrictions on resale and transfer in accordance with applicable securities laws and stock exchange policies, and will be subject to a four-month hold period from the date of grant.

About Nexus Uranium Corp.

Nexus Uranium is a Canadian uranium exploration company focused on mineral exploration and development in the green energy sector. The Company holds five uranium projects in the United States: Chord and Wolf Canyon in South Dakota; South Pass and Great Divide Basin in Wyoming; and Wray Mesa in Utah. These projects have seen extensive historical exploration and are located in prospective development areas. Nexus also holds the Mann Lake uranium project in the Athabasca Basin of northern Saskatchewan, Canada.

Forward-Looking Statements

This news release contains forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the anticipated contributions of the Company's advisory board and the advancement of the Company's uranium projects. Forward-looking information is based on assumptions considered reasonable by management at the date of this news release, including the continued availability of the Company's advisors and management team, and the Company's ability to execute on its business plans. Actual results may differ materially due to risks and uncertainties, including changes in market conditions, regulatory developments, and risks inherent to the mineral exploration industry. The Company undertakes no obligation to update forward-looking statements except as required by law.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the Company's securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The Company's securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277273

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

TORTOLA, British Virgin Islands--(BUSINESS WIRE)---- $ARB #AI--Pheasant Network raised 2M USD led by mint with Ethereum Foundation support to advance AI Intent cross chain tech and expand $PNT and AI routing.

These Wall Street analysts expect shares of Palantir and Intel to crash in the next year.

Year to date, Palantir Technologies (PLTR +0.19%) stock has returned 140% and Intel (INTC +0.47%) stock has returned 101%. However, certain Wall Street analysts believe the stocks are wildly overvalued. Following are the most pessimistic 12-month forecasts.

Rishi Jaluria at RBC Capital has set Palantir with a target price of $50 per share. That implies 72% downside from its current share price of $181.
Matt Bryson at Wedbush and Amanda Tan at DBS Bank have set Intel with a target price of $20 per share. That implies 50% downside from its current share price of $40.50.

Here's what investors should know about Palantir and Intel.

Image source: Getty Images.

Palantir Technologies: 72% implied downside
Palantir builds data analytics and artificial intelligence (AI) platforms for customers in the public and private sectors. Its key differentiator is ontology-based software, meaning its products are designed around a decisioning framework made more effective over time by machine learning (ML) models. Use cases span supply chain management, retail inventory optimization, financial fraud detection, and battlefield analytics.

Last year, Forrester Research recognized Palantir as the most capable AI/ML platform on the market, ranking it above Alphabet's Google, Amazon Web Services, and Microsoft Azure. The analysts wrote, "Palantir is quietly becoming one of the largest players in this market." Earlier this year, Forrester ranked Palantir as a leader in AI decisioning platforms.

Glowing recognition from industry analysts has come alongside strong financial results. In the third quarter, Palantir's revenue rose 63% to $1.1 billion, the ninth straight acceleration, and non-GAAP earnings more than doubled to $0.21 per diluted share. Management said strong demand for its artificial intelligence platform was key to its strong performance.

The problem with Palantir is valuation. Shares currently trade at 160 times sales, which makes it the most expensive stock in the S&P 500 by a wide margin. AppLovin is the next closest stock at 57 times sales. That means Palantir could lose nearly two-thirds of its value and still be the most expensive stock in the index.

Palantir has a strong competitive position in AI platforms, a market forecast to grow at 38% annually through 2033. But the valuation "seems unsustainable," according to Rishi Jaluria at RBC Capital. I completely agree. Palantir shares may move higher in the coming months, but a major correction is almost inevitable at some point. Investors should either avoid the stock or keep any positions very small.

Today's Change

(

0.19

%) $

0.35

Current Price

$

181.84

Intel: 50% implied downside
Intel is the market leader in central processing unit (CPU) sales across personal computers and data center servers, but the company has lost substantial market share in both CPU categories to AMD and Arm. Intel sees an opportunity to benefit as AI drives demand for CPUs, but the company has so far failed to capitalize. In fact, it famously passed on an opportunity to invest in OpenAI in 2017.

Meanwhile, Intel Foundry, the external chip manufacturing business that was launched in 2021, only recently won its first major customer (reportedly Microsoft). Initially, Intel aimed to surpass Samsung as the second-largest foundry by the end of the decade, but the odds of that happening are quite slim. Intel's history of execution missteps is unlikely to inspire confidence.

Importantly, Intel earlier this year said it may have to discontinue development of its next-generation 14A chip process technology and all leading-edge nodes thereafter if it cannot "secure a significant external customer." It's unclear whether the recent customer win will provide sufficient capital to prevent that outcome, so the company may yet have to exit the chip manufacturing business.

Intel reported 3% sales growth in the recent quarter. Meanwhile, AMD and Arm reported sales growth of 36% and 34%, respectively. Despite sluggish growth, Intel shares currently trade at 3.3 times sales, a premium to the five-year average of 2.4 times sales. I doubt the stock will fall 50%, but the combination of market share losses and a valuation that is high by historical standards is a good reason for investors to avoid the stock.

Trevor Jennewine has positions in Amazon and Palantir Technologies. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Intel, Microsoft, and Palantir Technologies. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.

-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial.

, /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that its New Drug Application (NDA) for denifanstat (ASC40), a first-in-class, once-daily oral small molecule fatty acid synthase (FASN) inhibitor for the treatment of moderate-to-severe acne vulgaris, has been accepted by the China National Medical Products Administration (NMPA).

"Acceptance of this NDA is an important milestone in our efforts to provide a potentially groundbreaking therapeutic approach for the treatment of moderate-to-severe acne," said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, "We are excited denifanstat (ASC40) is only one step away from the commercialization."

Ascletis has completed Phase II (NCT05104125) and Phase III (NCT06192264) studies of denifanstat (ASC40) for the treatment of moderate-to-severe acne vulgaris.

In the Phase III study, denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo. Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. All denifanstat (ASC40)-related treatment-emergent adverse events (TEAEs) were mild (Grade 1) or moderate (Grade 2). There were no denifanstat (ASC40)-related Grade 3 or 4 TEAEs and no denifanstat (ASC40)-related serious adverse events (SAEs). There were no denifanstat (ASC40)-related permanent treatment discontinuations or withdrawals observed.

The Phase III study results were presented as an oral presentation at the European Academy of Dermatology and Venereology (EADV) Congress 2025 in Paris, France on September 17, 2025 (link).

The Company recently completed the pre-NDA consultation with the China NMPA for denifanstat (ASC40) for the treatment of moderate-to-severe acne vulgaris and received positive feedback from NMPA.

Ascletis licensed denifanstat (ASC40) from Sagimet Biosciences Inc. (Nasdaq: SGMT) for exclusive rights in Greater China.

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug candidates in-house, including both small molecules and peptides, such as its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, an oral GLP-1R/GIPR/GCGR triple peptide agonist for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

For more information, please visit www.ascletis.com.

Contact：

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
[email protected] 

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
[email protected]
[email protected] 

SOURCE Ascletis Pharma Inc.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

AGNC Investment and W.P. Carey are both dividend cutters; here's why one is a better bet for dividend lovers.

Dividend investors love high-yield stocks and can often get so enamored of a yield that they overlook important facts about an investment. AGNC Investment (AGNC 1.43%) is a good example of this: Its huge 13.7% yield is so enticing that many investors overlook the fact that it is an unreliable dividend payer.

Meanwhile, a dividend cut at W.P. Carey (WPC 0.17%) in 2023 will often leave it on the sidelines despite an attractive 5.5% yield. Here's why most long-term income investors will be better off with W.P. Carey than AGNC Investment.

What are you looking for?
If you are like most dividend investors, your goal is to use the income generated by your portfolio to help support you during retirement. What you are likely trying to find are stocks that have attractive yields backed by dividends that have an opportunity to grow over time. This approach to investing has proved attractive and successful for generations.

Image source: Getty Images.

However, there are two pieces to the equation that you must balance. How much dividend yield do you need, and how much risk are you willing to take on? The biggest risk is a dividend cut, particularly if you are using the income you generate to cover essential living expenses. This is where AGNC Investment should fall off most dividend investors' radar screens.

AGNC Investment is a mortgage real estate investment trust (mREIT). It is a fairly complex niche within the REIT sector, known for offering extremely high yields. AGNC's yield, as noted above, is a huge 13.7%.

What's backing that yield is a portfolio of mortgages that have been pooled together into bond-like securities. There are numerous moving parts involved, including housing market dynamics, mortgage repayment rates, and interest rates, among others. In some ways, AGNC is essentially managing a portfolio of mortgage-backed securities.

AGNC data by YCharts.

Although the yield is huge, dividend investors shouldn't get too excited. As the chart above highlights, the payout has been highly volatile over time, though in recent years it's been in one direction -- down. It isn't a bad company, per se; it just isn't a particularly reliable dividend stock if your goal is to generate a reliable income stream.

Not all dividend cuts are the same
The thing is, it is fairly normal for mortgage REITs like AGNC to cut their dividends. They also raise them at times. However, fluctuating dividends make budgeting impossible if you rely on them to cover your living expenses.

But don't overlook all REITs that have cut their dividends, with property-owning REIT W.P. Carey being a prime example of a dividend cutter you might want to buy today.

In 2023, W.P. Carey trimmed its dividend. It was just one year shy of reaching 25 years of consecutive annual dividend increases. Something terrible must have happened, right?

Not really. Management and the board of directors made a tough decision to sell a number of properties and exit the troubled office sector in a single swift move. It was a large enough change that the dividend had to be reset lower.

WPC data by YCharts.

This decision was made from a position of strength, as the company began to raise the dividend in the very next quarter. It has been increased every quarter since, which was the same cadence that existed before the cut.

Moreover, W.P. Carey used the proceeds from the office sale to invest in new industrial, warehouse, and retail properties. The property owning REIT's growth has actually picked up steam, as shown by management raising its full-year forecast when it announced third-quarter 2025 earnings.

Given the long history of dividend increases before the office exit and the swift return to dividend growth, W.P. Carey and its healthy 5.5% yield are actually quite attractive. Yes, you have to get over the dividend cut. But if you do, you will likely find you like what you see.

High yields are bad, and dividend cuts are good?
Don't read too far into the point being made here. Not all high-yield stocks are risky dividend investments. Nonetheless, AGNC remains an unreliable income generator that most dividend investors will likely want to avoid, given its history of dividend cuts.

However, don't just ignore an attractive business because of a dividend cut. W.P. Carey is a testament to this, with its return to dividend growth indicating that the cut was strategic, and it appears to have positioned the company well for the future.

HomeStock IdeasLong IdeasTech 

SummaryViavi Solutions is positioned for growth and margin expansion, driven by the Spirent acquisition and strong NSE segment momentum.Q1 FY26 results showed 26% YoY revenue growth, 60% non-GAAP gross margin, and 15.7% operating margin, reflecting structural improvements.Spirent assets add ~$200M annual run-rate, diversify revenue streams, and enhance margin stability by increasing exposure to higher-quality lab and security testing.I expect a stock rerating as integration progresses, margins stabilize, and cash flow supports leverage; recommend buying before Q2 results. Erik Isakson/DigitalVision via Getty Images

I like Viavi Solutions Inc. (VIAV) because it is starting to carry multiple engines that can support its growth, margin expansion, and better cash generation. Back in September, I highlighted the fact

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You

The insurer Aegon on Wednesday it's relocating its headquarters from the Netherlands to the U.S. and renaming itself Transamerica, as part of its ambition to become a leading U.S. life insurance and retirement company.

Alibaba Group Holding Limited (BABA) September Quarter 2025 Results Earnings Conference November 25, 2025 7:30 AM ET

Company Participants

Fan Jiang - Chief Executive Officer of Alibaba E- commerce Business Group
Hong Xu - Chief Financial Officer
Lydia Lu - Head of Investor Relations
Yongming Wu - CEO, Head of Core E-Commerce Business & Director

Conference Call Participants

Alex C. Yao - JPMorgan Chase & Co, Research Division
Ellie Jiang - Macquarie Research
Gary Yu - Morgan Stanley, Research Division
Jialong Shi - Nomura Securities Co. Ltd., Research Division
Kenneth Fong - UBS Investment Bank, Research Division
Ronald Keung - Goldman Sachs Group, Inc., Research Division

Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to Alibaba Group's September Quarter 2025 Results Conference Call.

[Operator Instructions] I would now like to turn the call over to Lydia Lu, Head of Investor Relations of Alibaba Group. Please go ahead.

Lydia Lu

Thank you. Good day, everyone. Welcome to our September quarter 2025 earnings conference call. With me today from Alibaba are Joe Tsai, Chairman; Eddie Wu, Chief Executive Officer; Toby Xu, Chief Financial Officer; Jiang Fan, Chief Executive Officer of Alibaba E-commerce Business Group.

I would like to remind you that this call is also being webcast on our corporate website. A replay of the call will be available on our website later today.

Just a few forward-looking statements before we begin today. Today's discussions may contain forward-looking statements, particularly statements about our business and financial results that are subject to risks and uncertainties, which could cause actual results to differ materially from those contained in the forward-looking statements.

Please refer to the safe harbor statements that appear in our press release and investor presentation provided today. Please note that certain financial measures that we use on this call

KYND cyber intelligence integrates into Verisk’s Rulebook, as new KYND research reveals 80 percent of the UK’s top retailers are vulnerable to cyber threats

December 10, 2025 05:00 ET

 | Source:

Verisk Analytics, Inc.

LONDON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, announced today an expansion of its strategic collaboration with KYND to bring enriched cyber risk intelligence to the insurance market.

KYND’s cyber risk insights are now integrated into Verisk’s Rulebook platform, which supports pricing, underwriting and distribution services for all major classes of business. By combining Verisk’s global insurance expertise with KYND’s advanced cyber intelligence, this product integration provides insurers and brokers with seamless access to actionable intelligence, enabling more informed underwriting and risk management decisions.

Holiday Season Brings Heightened Cyber Risks

This expanded collaboration comes as new research from KYND reveals that 80 percent of the UK’s top 50 retailers are exposed to at least one critical cyber vulnerability, with more than a third facing simultaneous risks across all five major categories: ransomware, outdated software, vulnerable services, email security flaws and certificate issues.

“This research reveals that cyber threats are escalating across consumer-facing industries, especially ahead of the holiday season. Retailers hold vast customer data and operate complex supply chains, making them prime targets,” said Andy Thomas, CEO and Founder of KYND. “Our mission is simple: make complex cyber risks easy to see, understand and underwrite. We look forward to supporting insurers alongside Verisk with this collaboration.”

Driving Cyber Resilience Across the Insurance Ecosystem

Verisk aims to build resilience across the insurance value chain, centered on data-driven innovation and advanced technology. This collaboration with KYND reflects a shared commitment to enhancing the tools and insights available to the market, ensuring it can keep pace with the ever-changing nature of cyber threats.

“This deeper collaboration marks a step change in how cyber risk can be understood and managed across the insurance value chain,” said Tim Rayner, CEO, Verisk Specialty Business Solutions. “With KYND’s intelligence embedded into Rulebook, we’re empowering our clients to make faster, better-informed decisions to modernize commercial underwriting and strengthen resilience through data-driven insights. This is just the first of many ways our collaboration with KYND will deliver added value to Verisk’s clients, helping them stay ahead in an evolving cyber risk landscape.”

To learn more about Verisk and KYND’s strategic partnership, please visit: Verisk’s Sequel hub.

ENDS

About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work and fosters an inclusive culture where all team members feel they belong. For more, visit Verisk.com and the Verisk Newsroom.

About KYND
Founded in 2018 with a mission to help organisations see, understand, and manage cyber risks more easily and quickly than ever before, KYND has become a trusted cyber risk management partner to the insurance industry. It delivers actionable cyber risk intelligence combined with expert advisory services to support informed decision-making across the cyber insurance ecosystem.

Contact Data

Morgan Hurley
Verisk
551-655-7858
[email protected]

An us-versus-them mentality has emerged between Meta's top artificial intelligence team and longtime lieutenants to Mark Zuckerberg.

About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

Meta Platforms is upgraded to Buy, reflecting strong core business metrics and undervaluation relative to historic P/E multiples. META's Family of Apps segment delivers robust profitability, with net profit margin above 30% and ROIC exceeding 23%, underscoring competitive advantage. Heavy CapEx—$62.7B TTM, 84% of net profit—targets AI and Reality Labs, but success in Reality Labs remains elusive and is a key risk.

LuxExperience remains a compelling 'Buy' with a low 0.35x EV/S multiple and a multi-year recovery plan underway. Divestiture of THE OUTNET for $30 million streamlines operations, enabling focus on full-price segments and margin improvement. Q1 FY 2026 results show margin expansion, disciplined SG&A reduction, and strong AOV growth, particularly at MyTheresa and NET-A-PORTER.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Demand remained high, with 34.7 million people booking with TUI in fiscal 2025, up 5%, and revenue growing 4.4%.

Dominic Soon, the Head of APAC Credit Research at Debtwire, discusses China Vanke's liquidity troubles and touches on what this could mean for the broader Chinese property sector,

HomeStock IdeasLong IdeasFinancials 

SummaryBlock, Inc. is rated a buy as Cash App drives robust growth, with margins at all-time highs and shares trading at a steep discount.XYZ raised full-year guidance, expecting adjusted operating income of $2.056 billion, up 28%, despite Q3 earnings and revenue missing analyst expectations.Cash App, now with 58 million monthly actives, leads gross profit growth and is rapidly expanding among younger generations and primary banking users.XYZ’s valuation metrics—PE, PB, and PS ratios—are well below historical levels, supporting a compelling entry point as the firm’s financial ecosystem gains traction. Alistair Berg/DigitalVision via Getty Images

Block, Inc. (XYZ) (BSQKZ) currently trades just above $60 a share with a market cap of $37.2 billion. The fintech powerhouse traded at a similar price in 2019 pre-pandemic. XYZ reached $270 per share in 2021

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You

Europe's second-highest court on Wednesday rejected U.S. chipmaker Intel's challenge against a 376 million euros ($438 million) EU antitrust fine imposed two years ago for thwarting rivals, but cut the fine by 140 million euros.

Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript